{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T21:18:27Z","timestamp":1761167907808,"version":"build-2065373602"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T00:00:00Z","timestamp":1761004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T00:00:00Z","timestamp":1761004800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Onc"],"DOI":"10.1007\/s12672-025-03724-4","type":"journal-article","created":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T10:52:49Z","timestamp":1761043969000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Potential causal association and mechanistic insights of chronic HBV infection in extrahepatic cancer progression"],"prefix":"10.1007","volume":"16","author":[{"given":"Zhihui","family":"Wei","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weiqiang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,21]]},"reference":[{"issue":"3","key":"3724_CR1","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1001\/jamaoncol.2021.6987","volume":"8","author":"JM Kocarnik","year":"2022","unstructured":"Kocarnik JM, Compton K, Dean FE, et al. Cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life years for 29 cancer groups from 2010 to 2019: a systematic analysis for the Global Burden of Disease Study 2019. JAMA Oncol. 2022;8(3):420\u201344.","journal-title":"JAMA Oncol"},{"issue":"1","key":"3724_CR2","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1186\/s13045-021-01213-z","volume":"14","author":"L Lin","year":"2021","unstructured":"Lin L, Li Z, Yan L, Liu Y, Yang H, Li H. Global, regional, and national cancer incidence and death for 29 cancer groups in 2019 and trends analysis of the global cancer burden, 1990\u20132019. J Hematol Oncol. 2021;14(1):197.","journal-title":"J Hematol Oncol"},{"issue":"4","key":"3724_CR3","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1001\/jamaoncol.2022.7826","volume":"9","author":"S Chen","year":"2023","unstructured":"Chen S, Cao Z, Prettner K, et al. Estimates and projections of the global economic cost of 29 cancers in 204 countries and territories from 2020 to 2050. JAMA Oncol. 2023;9(4):465\u201372.","journal-title":"JAMA Oncol"},{"issue":"2","key":"3724_CR4","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.eururo.2023.04.021","volume":"84","author":"O Bergengren","year":"2023","unstructured":"Bergengren O, Pekala KR, Matsoukas K, et al. 2022 update on prostate cancer epidemiology and risk factors-a systematic review. Eur Urol. 2023;84(2):191\u2013206.","journal-title":"Eur Urol"},{"issue":"3","key":"3724_CR5","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209\u201349.","journal-title":"CA Cancer J Clin"},{"issue":"2","key":"3724_CR6","doi-asserted-by":"publisher","first-page":"e180","DOI":"10.1016\/S2214-109X(19)30488-7","volume":"8","author":"C de Martel","year":"2020","unstructured":"de Martel C, Georges D, Bray F, Ferlay J, Clifford GM. Global burden of cancer attributable to infections in 2018: a worldwide incidence analysis. Lancet Glob Health. 2020;8(2):e180\u201390.","journal-title":"Lancet Glob Health"},{"key":"3724_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.canlet.2021.06.027","volume":"520","author":"J Cai","year":"2021","unstructured":"Cai J, Chen H, Lu M, et al. Advances in the epidemiology of pancreatic cancer: trends, risk factors, screening, and prognosis. Cancer Lett. 2021;520:1\u201311.","journal-title":"Cancer Lett"},{"key":"3724_CR8","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1222651","volume":"14","author":"Q Chen","year":"2023","unstructured":"Chen Q, Qu L, He Y, Deng Y, Zhou Q, Yi W. Comparative effectiveness of nipple-sparing mastectomy and breast-conserving surgery on long-term prognosis in breast cancer. Front Endocrinol (Lausanne). 2023;14:1222651.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"3724_CR9","first-page":"7","volume":"72","author":"RL Siegel","year":"2022","unstructured":"Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2022. CA Cancer J Clin. 2022;72(1):7\u201333.","journal-title":"CA Cancer J Clin"},{"issue":"7781","key":"3724_CR10","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/s41586-019-1694-1","volume":"575","author":"J Canon","year":"2019","unstructured":"Canon J, Rex K, Saiki AY, et al. The clinical KRAS(G12C) inhibitor AMG 510 drives anti-tumour immunity. Nature. 2019;575(7781):217\u201323.","journal-title":"Nature"},{"issue":"1","key":"3724_CR11","doi-asserted-by":"publisher","first-page":"300060523122136","DOI":"10.1177\/03000605231221361","volume":"52","author":"Z Chen","year":"2024","unstructured":"Chen Z, Ding C, Chen J, Zheng S, Li Q. Pan-cancer analysis revealing the multidimensional expression and prognostic and immunologic roles of TGFB1 in cancer. J Int Med Res. 2024;52(1):3000605231221361.","journal-title":"J Int Med Res"},{"issue":"1","key":"3724_CR12","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1007\/s40615-023-01526-4","volume":"11","author":"YR Hong","year":"2024","unstructured":"Hong YR, Yadav S, Wang R, et al. Genetic testing for cancer risk and perceived importance of genetic information among US population by race and ethnicity: a cross-sectional study. J Racial Ethn Health Disparities. 2024;11(1):382\u201394.","journal-title":"J Racial Ethn Health Disparities"},{"key":"3724_CR13","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13246254","author":"C Pedrazzani","year":"2021","unstructured":"Pedrazzani C, Ming C, B\u00fcrki N, et al. Genetic literacy and communication of genetic information in families concerned with hereditary breast and ovarian cancer: a cross-study comparison in two countries and within a timeframe of more than 10 years. Cancers (Basel). 2021. https:\/\/doi.org\/10.3390\/cancers13246254.","journal-title":"Cancers (Basel)"},{"key":"3724_CR14","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00046-19","author":"MH Nguyen","year":"2020","unstructured":"Nguyen MH, Wong G, Gane E, Kao JH, Dusheiko G. Hepatitis B virus: advances in prevention, diagnosis, and therapy. Clin Microbiol Rev. 2020. https:\/\/doi.org\/10.1128\/CMR.00046-19.","journal-title":"Clin Microbiol Rev"},{"key":"3724_CR15","doi-asserted-by":"publisher","DOI":"10.1111\/jvh.13988","author":"A Mahajan","year":"2024","unstructured":"Mahajan A, Kharawala S, Desai S, Kendrick S, Das J, Gielen V. Association of hepatitis B surface antigen levels with long-term complications in chronic hepatitis B virus infection: a systematic literature review. J Viral Hepat. 2024. https:\/\/doi.org\/10.1111\/jvh.13988.","journal-title":"J Viral Hepat"},{"key":"3724_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2020.104925","volume":"182","author":"S Tsukuda","year":"2020","unstructured":"Tsukuda S, Watashi K. Hepatitis B virus biology and life cycle. Antiviral Res. 2020;182:104925.","journal-title":"Antiviral Res"},{"key":"3724_CR17","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11216247","author":"C Mazzaro","year":"2022","unstructured":"Mazzaro C, Adinolfi LE, Pozzato G, et al. Extrahepatic manifestations of chronic HBV infection and the role of antiviral therapy. J Clin Med. 2022. https:\/\/doi.org\/10.3390\/jcm11216247.","journal-title":"J Clin Med"},{"key":"3724_CR18","doi-asserted-by":"publisher","first-page":"1141956","DOI":"10.3389\/fimmu.2023.1141956","volume":"14","author":"Y Min","year":"2023","unstructured":"Min Y, Wei X, Xia X, et al. Hepatitis B virus infection: an insight into the clinical connection and molecular interaction between hepatitis B virus and host extrahepatic cancer risk. Front Immunol. 2023;14:1141956.","journal-title":"Front Immunol"},{"issue":"6","key":"3724_CR19","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2019.5718","volume":"2","author":"C Song","year":"2019","unstructured":"Song C, Lv J, Liu Y, et al. Associations between hepatitis B virus infection and risk of all cancer types. JAMA Netw Open. 2019;2(6):e195718.","journal-title":"JAMA Netw Open"},{"key":"3724_CR20","volume":"375","author":"VW Skrivankova","year":"2021","unstructured":"Skrivankova VW, Richmond RC, Woolf BAR, et al. Strengthening the reporting of observational studies in epidemiology using Mendelian randomisation (STROBE-MR): explanation and elaboration. BMJ (Clinical research ed). 2021;375:n2233.","journal-title":"BMJ (Clinical research ed)"},{"issue":"10","key":"3724_CR21","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1038\/s41588-021-00931-x","volume":"53","author":"S Sakaue","year":"2021","unstructured":"Sakaue S, Kanai M, Tanigawa Y, et al. A cross-population atlas of genetic associations for 220 human phenotypes. Nat Genet. 2021;53(10):1415\u201324.","journal-title":"Nat Genet"},{"key":"3724_CR22","doi-asserted-by":"publisher","DOI":"10.3390\/nu14204434","author":"J Chen","year":"2022","unstructured":"Chen J, Zhou H, Jin H, Liu K. Role of inflammatory factors in mediating the effect of lipids on nonalcoholic fatty liver disease: a two-step, multivariable Mendelian randomization study. Nutrients. 2022. https:\/\/doi.org\/10.3390\/nu14204434.","journal-title":"Nutrients"},{"key":"3724_CR23","doi-asserted-by":"publisher","first-page":"1285106","DOI":"10.3389\/fimmu.2023.1285106","volume":"14","author":"P Fang","year":"2023","unstructured":"Fang P, Liu X, Qiu Y, et al. Exploring causal correlations between inflammatory cytokines and ankylosing spondylitis: a bidirectional mendelian-randomization study. Front Immunol. 2023;14:1285106.","journal-title":"Front Immunol"},{"issue":"1","key":"3724_CR24","doi-asserted-by":"publisher","first-page":"25644","DOI":"10.1038\/s41598-024-77105-2","volume":"14","author":"R Ming","year":"2024","unstructured":"Ming R, Wu H, Wu Z. Causal relationships between three plasma proteins and non-alcoholic fatty liver disease, mediated by Epstein-barr virus EA-D antibody levels: a mendelian randomization study. Sci Rep. 2024;14(1):25644.","journal-title":"Sci Rep"},{"issue":"3","key":"3724_CR25","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1093\/ije\/dyr036","volume":"40","author":"S Burgess","year":"2011","unstructured":"Burgess S, Thompson SG, Collaboration CCG. Avoiding bias from weak instruments in Mendelian randomization studies. Int J Epidemiol. 2011;40(3):755\u201364.","journal-title":"Int J Epidemiol"},{"issue":"11","key":"3724_CR26","doi-asserted-by":"publisher","first-page":"3253","DOI":"10.1681\/ASN.2016010098","volume":"27","author":"P Sekula","year":"2016","unstructured":"Sekula P, Del Greco MF, Pattaro C, K\u00f6ttgen A. Mendelian randomization as an approach to assess causality using observational data. J Am Soc Nephrol. 2016;27(11):3253\u201365.","journal-title":"J Am Soc Nephrol"},{"key":"3724_CR27","doi-asserted-by":"publisher","first-page":"1288525","DOI":"10.3389\/fmicb.2023.1288525","volume":"14","author":"Z Chen","year":"2023","unstructured":"Chen Z, Shi W, Chen K, Lu C, Li X, Li Q. Elucidating the causal association between gut microbiota and intrahepatic cholangiocarcinoma through Mendelian randomization analysis. Front Microbiol. 2023;14:1288525.","journal-title":"Front Microbiol"},{"issue":"8","key":"3724_CR28","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1038\/s41575-023-00760-9","volume":"20","author":"YC Hsu","year":"2023","unstructured":"Hsu YC, Huang DQ, Nguyen MH. Global burden of hepatitis B virus: current status, missed opportunities and a call for action. Nat Rev Gastroenterol Hepatol. 2023;20(8):524\u201337.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"3724_CR29","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.m2200","volume":"370","author":"Y Shi","year":"2020","unstructured":"Shi Y, Zheng M. Hepatitis B virus persistence and reactivation. BMJ. 2020;370:m2200.","journal-title":"BMJ"},{"issue":"12","key":"3724_CR30","doi-asserted-by":"publisher","first-page":"2354","DOI":"10.1136\/gutjnl-2023-330691","volume":"72","author":"Z Liu","year":"2023","unstructured":"Liu Z, Lin C, Mao X, et al. Changing prevalence of chronic hepatitis B virus infection in China between 1973 and 2021: a systematic literature review and meta-analysis of 3740 studies and 231 million people. Gut. 2023;72(12):2354\u201363.","journal-title":"Gut"},{"issue":"2","key":"3724_CR31","doi-asserted-by":"publisher","first-page":"253","DOI":"10.14309\/ajg.0000000000001575","volume":"117","author":"P Cacoub","year":"2022","unstructured":"Cacoub P, Asselah T. Hepatitis B virus infection and extra-hepatic manifestations: a systemic disease. Am J Gastroenterol. 2022;117(2):253\u201363.","journal-title":"Am J Gastroenterol"},{"key":"3724_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2022.104003","volume":"79","author":"AB Kamiza","year":"2022","unstructured":"Kamiza AB, Fatumo S, Singini MG, Yeh CC, Chikowore T. Hepatitis B infection is causally associated with extrahepatic cancers: a Mendelian randomization study. EBioMedicine. 2022;79:104003.","journal-title":"EBioMedicine"},{"issue":"1","key":"3724_CR33","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/s41571-021-00549-2","volume":"19","author":"R Dhanasekaran","year":"2022","unstructured":"Dhanasekaran R, Deutzmann A, Mahauad-Fernandez WD, Hansen AS, Gouw AM, Felsher DW. The MYC oncogene - the grand orchestrator of cancer growth and immune evasion. Nat Rev Clin Oncol. 2022;19(1):23\u201336.","journal-title":"Nat Rev Clin Oncol"},{"issue":"7971","key":"3724_CR34","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1038\/s41586-023-06253-8","volume":"619","author":"AM Kaiser","year":"2023","unstructured":"Kaiser AM, Gatto A, Hanson KJ, et al. P53 governs an AT1 differentiation programme in lung cancer suppression. Nature. 2023;619(7971):851\u20139.","journal-title":"Nature"},{"issue":"25","key":"3724_CR35","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.4254\/wjh.v8.i25.1061","volume":"8","author":"CC Chao","year":"2016","unstructured":"Chao CC. Inhibition of apoptosis by oncogenic hepatitis B virus X protein: implications for the treatment of hepatocellular carcinoma. World J Hepatol. 2016;8(25):1061\u20136.","journal-title":"World J Hepatol"},{"issue":"14","key":"3724_CR36","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.2174\/1381612829666230503164755","volume":"29","author":"YC Zhang","year":"2023","unstructured":"Zhang YC, Gao WC, Chen WJ, Pang DX, Mo DY, Yang M. Network pharmacology and molecular docking analysis on molecular targets and mechanisms of Fei Jin Sheng formula in the treatment of lung cancer. Curr Pharm Des. 2023;29(14):1121\u201334.","journal-title":"Curr Pharm Des"},{"issue":"1","key":"3724_CR37","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1186\/s12931-024-02989-7","volume":"25","author":"B Yue","year":"2024","unstructured":"Yue B, Xiong D, Chen J, et al. SPP1 induces idiopathic pulmonary fibrosis and NSCLC progression via the PI3K\/Akt\/mTOR pathway. Respir Res. 2024;25(1):362.","journal-title":"Respir Res"},{"issue":"1","key":"3724_CR38","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1038\/s41523-024-00695-7","volume":"10","author":"SM Cha","year":"2024","unstructured":"Cha SM, Park JW, Lee YJ, et al. SPP1+ macrophages in HR+ breast cancer are associated with tumor-infiltrating lymphocytes. NPJ Breast Cancer. 2024;10(1):83.","journal-title":"NPJ Breast Cancer"},{"key":"3724_CR39","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202400524","author":"L Dong","year":"2024","unstructured":"Dong L, Hu S, Li X, et al. SPP1(+) TAM regulates the metastatic colonization of CXCR4(+) metastasis-associated tumor cells by remodeling the lymph node microenvironment. Adv Sci (Weinh). 2024. https:\/\/doi.org\/10.1002\/advs.202400524.","journal-title":"Adv Sci (Weinh)"},{"issue":"9\u201310","key":"3724_CR40","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1007\/s10495-024-01994-x","volume":"29","author":"Z Zhang","year":"2024","unstructured":"Zhang Z, Chen X, Li Y, et al. The resistance to anoikis, mediated by Spp1, and the evasion of immune surveillance facilitate the invasion and metastasis of hepatocellular carcinoma. Apoptosis. 2024;29(9\u201310):1564\u201383.","journal-title":"Apoptosis"},{"key":"3724_CR41","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics12051101","author":"Z Zhang","year":"2022","unstructured":"Zhang Z, Han S, Ouyang S, et al. PDK4 constitutes a novel prognostic biomarker and therapeutic target in gastric cancer. Diagnostics. 2022. https:\/\/doi.org\/10.3390\/diagnostics12051101.","journal-title":"Diagnostics"},{"issue":"6","key":"3724_CR42","doi-asserted-by":"publisher","first-page":"81","DOI":"10.21037\/cco.2016.08.04","volume":"5","author":"VP Adhikari","year":"2016","unstructured":"Adhikari VP, Lu LJ, Kong LQ. Does hepatitis B virus infection cause breast cancer? Chin Clin Oncol. 2016;5(6):81.","journal-title":"Chin Clin Oncol"},{"issue":"1","key":"3724_CR43","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s13045-018-0577-5","volume":"11","author":"B Liu","year":"2018","unstructured":"Liu B, Wang T, Wang H, et al. Oncoprotein HBXIP enhances HOXB13 acetylation and co-activates HOXB13 to confer tamoxifen resistance in breast cancer. J Hematol Oncol. 2018;11(1):26.","journal-title":"J Hematol Oncol"},{"issue":"3","key":"3724_CR44","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1016\/j.apsb.2022.11.025","volume":"13","author":"L Zhang","year":"2023","unstructured":"Zhang L, Zhou X, Liu B, et al. HBXIP blocks myosin-IIA assembly by phosphorylating and interacting with NMHC-IIA in breast cancer metastasis. Acta Pharm Sin B. 2023;13(3):1053\u201370.","journal-title":"Acta Pharm Sin B"},{"issue":"7916","key":"3724_CR45","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1038\/s41586-022-04845-4","volume":"606","author":"J Asami","year":"2022","unstructured":"Asami J, Kimura KT, Fujita-Fujiharu Y, et al. Structure of the bile acid transporter and HBV receptor NTCP. Nature. 2022;606(7916):1021\u20136.","journal-title":"Nature"},{"key":"3724_CR46","doi-asserted-by":"publisher","DOI":"10.3390\/cells9061486","author":"C Herrscher","year":"2020","unstructured":"Herrscher C, Roingeard P, Blanchard E. Hepatitis b virus entry into cells. Cells. 2020. https:\/\/doi.org\/10.3390\/cells9061486.","journal-title":"Cells"},{"issue":"1","key":"3724_CR47","first-page":"296","volume":"43","author":"B Qin","year":"2020","unstructured":"Qin B, Zhao K, Wei J, et al. Novel evidence indicates the presence and replication of hepatitis B virus in breast cancer tissue. Oncol Rep. 2020;43(1):296\u2013305.","journal-title":"Oncol Rep"},{"issue":"4","key":"3724_CR48","first-page":"1682","volume":"39","author":"Q Wang","year":"2018","unstructured":"Wang Q, Chen Y, Feng H, Zhang B, Wang H. Prognostic and predictive value of HURP in non-small cell lung cancer. Oncol Rep. 2018;39(4):1682\u201392.","journal-title":"Oncol Rep"}],"container-title":["Discover Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-03724-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12672-025-03724-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-03724-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T23:03:58Z","timestamp":1761087838000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12672-025-03724-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,21]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3724"],"URL":"https:\/\/doi.org\/10.1007\/s12672-025-03724-4","relation":{},"ISSN":["2730-6011"],"issn-type":[{"type":"electronic","value":"2730-6011"}],"subject":[],"published":{"date-parts":[[2025,10,21]]},"assertion":[{"value":"15 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable as this is not a study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"This study has been approved for publication by Shulan (Hangzhou) Hospital affiliated with Zhejiang Shuren University, Shulan International Medical College, and Shulan (Quzhou) Hospital. The authors confirm the authenticity of the manuscript content, declare no conflicts of interest, and have obtained consent from all authors and their respective institutions for submission.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1939"}}